Doctor of Podiatric Medicine Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Kiana Karbasi

Podiatrist, Foot & Ankle Surgery Orlando, FL Doctor of Podiatric Medicine

NPI 1194189589 CMS profile 8258762

3701 Avalon Park West Blvd Ste 225, Orlando, FL 32828

Open in the dashboard

General payments

$93,729

153 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kiana Karbasi of Orlando, FL is reported in the CMS Open Payments database as having received $93,729 across 153 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,830 23
2024 General $61,150 38
2023 General $14,443 48
2022 General $6,606 37
2021 General $1,423 4
2020 General $276 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kiana Karbasi
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Kiana Karbasi were reported at $9,830. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Kiana Karbasi Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $0 $389 $118–$1,406 $163
2020 $276 $191 $62–$691 $114
2021 $1,423 $329 $104–$1,341 $132
2022 $6,606 $419 $125–$1,611 $149
2023 $14,443 $377 $128–$1,164 $160
2024 $61,150 $394 $134–$1,168 $164
2025 $9,830 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. ConvaTec Inc. $83,114 71 payments
  2. Triad Life Sciences Inc. $4,523 20 payments
  3. Fones Marketing Management, Inc. $2,453 3 payments
  4. Arthrex, Inc. $1,035 14 payments
  5. Stryker Corporation $798 13 payments
  6. Linvatec Corporation $427 3 payments
  7. OSSIO Inc. $285 5 payments
  8. Paragon 28, Inc. $276 2 payments
  9. Sanara MedTech Inc. $199 2 payments
  10. Paratek Pharmaceuticals, Inc. $128 2 payments
  11. Other $491 18 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $39,670 13 payments
  2. Debt forgiveness $35,000 1 payment
  3. Travel and Lodging $7,992 21 payments
  4. Food and Beverage $7,917 115 payments
  5. Education $2,400 2 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $750 1 payment
Products named General payments · program years 2020–2025
  1. INNOVAMATRIX AC $87,528 90 payments
  2. VARIAX Trauma & Extremeties $290 3 payments
  3. BIOBRACE 23MM $284 2 payments
  4. INNOVAMATRIX PD $232 3 payments
  5. HOFFMANN $223 3 payments
  6. INFINITY $217 3 payments
  7. CellerateRx $199 2 payments
  8. ASNIS $175 2 payments
  9. VARIAX Trauma & Extremeties $168 1 payment
  10. SILVERBACK $150 1 payment
  11. Other $1,687 42 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

28

Median for Podiatry: 160

Drug cost

$604

Median for Podiatry: $2,368

Branded share of claims

0%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ciclopirox Generic 28 $604

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$7,315

Medicare's payments for the services billed

Medicare patients

34

Average age 73

Services billed

95

18 women, 16 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 68%
Arthritis 68%
Ischemic heart disease 62%
Heart failure 50%
Chronic kidney disease 50%
Atrial fibrillation 44%
Depression 41%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

153 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record